Intrauterine exposures to drug;Exposicion intrauterina a drogas

Revista de Neurologia

Volumn 25, Issue 141, 1997, Pages 691-702

  Legido, A ^a,b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

Author keywords

alcoholic fetal; cocaine; drugs; embryopathy; marijuana; opiates

Indexed keywords

ALCOHOL; CANNABIS; COCAINE; METHADONE; OPIATE; NARCOTIC AGENT;

CONFERENCE PAPER; DRUG ABUSE; FETAL ALCOHOL SYNDROME; FETUS; HUMAN; PRENATAL DEVELOPMENT; SUDDEN INFANT DEATH SYNDROME; CANNABIS SMOKING; COGNITIVE DEFECT; FEMALE; PREGNANCY; PRENATAL EXPOSURE; PSYCHOMOTOR DISORDER; REVIEW;

COCAINE; COGNITION DISORDERS; ETHANOL; FEMALE; HUMANS; MARIJUANA SMOKING; NARCOTICS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PSYCHOMOTOR DISORDERS;

EID: 0031132103     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (120)

1. Brust JCM. Neurological aspects of substance abuse. Stoneham, MA: Butterworth Heinemann, 1993.
2. Kandel DB. Epidemiological trends and implications for understanding the nature of addiction. Res Publ Assoc Res Nerv Ment Dis 1992; 70: 23-40.
3. Brust JCM. Disorders of the nervous system secondary to substance abuse. En Berg BO, ed. Principles of neurology. New York: McGraw-Hill, 1996: 1343-1362.
4. Vega WA, Zimmerman RS, Warheit GJ, et al. Risk factors for early adolescent drug use in four ethnic and racial groups. Am J Public Health 1993; 83: 185-189.
5. Kandel D, Yamaguchi K. From beer to crack: developmental patterns of drug involvement. Am J Public Health 1993; 83: 851-855.
6. Chiriboga CA, Ferriero DM. Neurologic complications of maternal drug abuse. En Berg BO, ed. Principles of neurology. New York: McGraw-Hill, 1996: 1363-1374.
7. Committee on Substance Abuse: fetal alcohol syndrome and fetal alcohol effects. Pediatrics 1993; 91: 1004-1006.
8. Volpe JJ. Teratogenic effects of drugs and passive addiction. En Volpe JJ. Neuroloey of the newborn. Philadelphia: WB Saunders Co., 1995; 811-850.
9. Abel EL, Sokol RJ. A revised conservative estimate of the incidence of FAS and its economic impact. Alcohol Clin Exp Res 1991; 15: 514-524.
10. Hagberg B, Hagberg G, Lewerth A, et al. Mild mental retardation in swedish school children. II. Etiologic and pathogenetic aspects. Acta Paediatr Scand 1981; 70: 445-452.
11. Maier SE, Chen WJA, West JR. The effects of timing and duration of alcohol exposure on development of the fetal brain. En Abel EL, ed. Fetal alcohol syndrome. From mechanism to prevention. Boca Raton: CRC Press, 1996; 27-50.
12. West JR, Hamre KM, Cassell MD. Effects of ethanol exposure during the third trimester equivalent on neuron number in rat hippocampus and dentate gyrus. Alcohol Clin Exp Res 1986; 10: 190-197.
13. Marcussen BI, Goodlett CR, Mahoney JC, West JR. Developing rat Purkinje cells are more vulnerable to alcohol-induced depletion during differentiation than during neurogenesis. Alcohol 1994; 11: 147-156.
14. Reynolds JD, Brien JF. Ethanol neurobehavioral teratogenesis and the role of L-glutamate in the fetal hippocampus. Can J Physiol Pharmacol 1995; 73: 1209-1223.
15. Saulnier JL, Randall CL. Involvement of prostaglandins in fetal alcohol syndrome. En Abel EL, ed. Fetal alcohol syndrome. From mechanism to prevention. Boca Raton: CRC Press, 1996: 249-268.
16. Duester G. A hypothetical mechanism for fetal alcohol syndrome involving ethanol inhibition of retinoic acid synthesis at the alcohol dehydrogenase step. Alcohol Clin Exp Res 1991; 15: 560-564.
17. Manteuffel MD. Neurotransmitter function: changes associated with in utero alcohol exposure. En Abel EL, ed. Fetal alcohol syndrome. From mechanism to prevention. Boca Raton: CRC Press, 1996: 171-189.
18. Legido A. Neurotransmisores y desarrollo cerebral: efectos fisiológicos y fisiopatológicos. Rev Neurol 1995; 23: S269-S277.
19. Heaton MB, Carlin M, Paiva M, Walker DW. Perturbation of target-directed neurite outgrowth in embryonic CNS co-cultures grown in the presence of ethanol. Dev Brain Res 1995; 89: 270-280.
20. Lancaster FE. Alcohol and white matter development. A review. Alcohol Clin Exp Res 1994; 18: 644-647.
21. Hungund BL, Mahadik SP. Role of gangliosides in behavioral and biochemical actions of alcohol: cell membrane structure and function. Alcohol Clin Exp Res 1993; 17: 329-339.
22. Ramanathan R, Wilkemeyer MF, Mittal B, Perides G. Alcohol inhibits cell-cell adhesion mediated by human L1. J Cell Biol 1996; 133: 381-390.
23. Streissguth AP, Dehaene P. Fetal alcohol syndrome in twins of alcoholic mothers: concordance of diagnosis and IQ. Am J Med Genet 1993; 47: 857-861.
24. Chiriboga CA. Neurologic complications of drug and alcohol abuse. Fetal effects. Neurol Clin 1993; 11: 707-728.
25. Chiriboga CA. Abuse of children: fetal and pediatric AIDS, fetal alcohol syndrome, fetal cocaine effects, and the battered child. En Rowland LP, ed. Merritt's textbook of neurology. Baltimore: Williams & Wilkins, 1995: 995-1000.
26. Froster UG, Baird PA. Congenital defects of the limbs and alcohol exposure in pregnancy: data from a population based study. Am J Med Genet 1992; 44: 782-785.
27. Coles CD. Early neurobehavioral assessment of children prenatally exposed to alcohol. En Abel EL, ed. Fetal alcohol syndrome. From mechanism to prevention. Boca Raton: CRC Press, 1996: 145-170.
28. Spoht HL, Willms J, Steinhausen HC. The fetal alcohol syndrome in adolescence. Acta Paediatr 1994; 404: 19-26.
29. Havlicek V, Childiaeva R, Chernik V. EEG frequency spectrum characteristics of sleep states in infants of alcoholic mothers. Neuro-pediatrie 1977; 8: 360-373.
30. Ioffe S, Chernick V. Prediction of subsequent motor and mental retar-dation in newborn infants exposed to alcohol in utero by computerized EEG analysis. Neuropediatrics 1990; 21: 11-17.
31. Pettigrew AG, Hutchinson I. Effects of alcohol on functional development of the auditory pathway in the brainstem of infants and chick embryos. En Wesy JR, ed. Mechanisms of alcohol damage in utero. New York: Oxford University Press, 1986; 10.
32. Riley EP, Mattson SN, Sowell ER, et al. Abnormalities of the corpus callosum in children prenatally exposed to alcohol. Alcohol Clin Exp Res 1995; 19: 1198-1202.
33. Swayze VW, Johnson VP, Hanson JW, et al. Magnetic resonance imaging of brain anomalies in fetal alcohol syndrome. Pediatrics 1997; 99: 232-240.
34. Mattson SN, Riley EP, Jernigan TL. Fetal alcohol syndrome: a case report of neuropsychological, MRI, and EEG assesment of two children. Alcohol Clin Exp Res 1992; 16: 1001-1003.
35. Mattson SN. Riley EP. Brain anomalies in fetal alcohol syndrome. En Abel EL, ed. Fetal alcohol syndrome. From mechanism to prevention. Boca Raton: CRC Press, 1996; 51-68.
36. Hungund BL, Gikhale VB, Mahadik SP. Ganglioside pretreatment protects the prenatal ethanol effects. Pediatr Res 1991; 15: 337A.
37. Schorling JB. The prevention of prenatal alcohol use: a critical analysis of intervention studies. J Stud Alcohol 1993; 54: 261-267.
38. Chiriboga CA. Cocaine and the fetus: methodological issues and neurologic correlates. En Konkol RJ, Olsen GD, eds. Prenatal cocaine exposure. Boca Raton: CRC Press, 1996; 1-21.
39. Kain ZN, Kain TS, Scarpelli EM. Cocaine exposure in utero: perinatal development and neonatal manifestations-review. Clin Toxicol 1992; 30: 607-636.
40. O'Malley PM, Johnston LD, Bachman JG. Quantitative and qualitative changes in cocaine use among american high school seniors, college students and young adults. NIDA Res Monogr 1991; 110: 19-43.
41. Volpe. Effect of cocaine use on the fetus. N Engl J Med 1992; 327: 399-407.
42. Vaughn AJ, Carzoli RP, Sánchez-Ramos L, et al. Community wide estimation of illicit drug use in delivering women: prevalence, demographic and associated risk factors. Obstet Gynecol 1993; 82: 92-96.
43. Burke MS, Roth D. Anonymous screening in private obstetric population. Obstet Gynecol 1993; 81: 354-356.
44. Anonymous. Population-based of perinatal exposure to cocaine. MMWR 1996; 45: 887-891.
45. Ostrea EM, Brady MJ, Gause S, et al. Drug screening of newborns by meconium analysis: a large scale, prospective, epidemiological study. Pediatrics 1992; 89: 107-113.
46. García DC, Romero A, García GC, Ostrea EM. Gastric fluid analysis for determining gestational cocaine exposure. Pediatrics 1996; 98: 291-293.
47. Singer L, Arendt R, Minnes S. Neurodevelopmental effects of cocaine. Clin Perinatol 1993; 20: 245-247.
48. Frank DA, Bresnahan K, Zuckerman BS. Maternal cocaine use: impact on child health and development. Adv Pediatr 1993; 40: 65-99.
49. Olsen GD, Schalock PC. Cocaine pharmacology and drug interaction in the fetal-maternal unit. En Konkol RJ, Olsen GD, eds. Prenatal cocaine exposure. Boca Raton: CRC Press, 1996; 23-34.
50. Glantz JC, Woods JR. Obstetrical pathophysiology of cocaine. En Konkol RJ, Olsen GD, eds. Prenatal cocaine exposure. Boca Raton: CRC Press, 1996; 35-67.
51. Schenker S, Yang Y, Johnson RF, et al. The transfer of cocaine and its metabolites across the term human placenta. Clin Pharmacol Ther 1993; 53: 329-339.
52. Olsen GD. Potential mechanisms of cocaine-induced developmental neurotoxicity: a mini review. Neurotoxicol 1995; 16: 159-167.
53. Sharkey J, McBean DE, Kelly PAT. Acute cocaine administration: effects on local cerebral blood flow and metabolic demand in the rat. Brain Res 1991; 548: 310-314.
54. Buchhalter JR. Does prenatal cocaine exposure cause strokes in neonates? Clinical evidence. En Konkol RJ, Olsen GD, eds. Prenatal cocaine exposure. Boca Raton: CRC Press, 1996; 69-73.
55. Fantel AG, Barber CV, Carda MB, et al. Studies of the role of ischemia/reperfusion: a new hypothesis for the developmental toxicity of cocaine. Teratology 1992; 46: 293-300.
56. Konkol RJ, Schuelke G. Behavioral and convulsive effects of cocaine metabolites: mechanisms and implications. En Konkol RJ, Olsen GD, eds. Prenatal cocaine exposure. Boca Raton: CRC Press, 1996; 95-113.
57. Leskawa KC, Jackson GH, Moody CA, Spear LP. Cocaine exposure during pregnancy affects rat neonate and maternal brain glycos-phingolipids. Brain Res Bull 1994; 33: 195-198.
58. Fantel AG, Person RE, Burroughs GC, et al. Direct embryotoxicity of cocaine in rats: effects on mitochondrial activity, cardiac function and growth and development in vitro. Teratology 1990; 42: 35-43.
59. Spear LP. Neurobehavioral consequences of gestational cocaine exposure: studies using a rodent model. En Konkol RJ, Olsen GD, eds. Prenatal cocaine exposure. Boca Raton: CRC Press, 1996; 169-181.
60. Seidler FJ, Temple SW, McCook EC, Slotkin TA. Cocaine inhibits central noradrenergic and dopaminergic activity during the critical developmental period in which catecholamines influence cell develop-ment. Brain Res 1995; 85: 48-53.
61. Akbari HM, Kramer HK, Whitaker-Azmitia PM, et al. Prenatal cocaine exposure disrupts the development of the serotonergic system. Brain Res 1992; 572: 57-63.
62. Tyrala EE, Mathews SV, Rao GS. Effect of intrauterine exposure to cocaine on acetylcholinesterase in primary cultures of fetal mouse brain cells. Neurotoxicol Teratol 1992; 14: 229-233.
63. Clow DW, Hammer RP, Kirstein CL, Spear LP. Gestational cocaine exposure increases opiate receptor binding in weanling offspring. Dev Brain Res 1991; 59: 179-185.
64. Zachor D, Cherkes JK, Fay CT, Ocrant L. Cocaine differentially inhibits neuronal differentiation and proliferation in vitro. J Clin Invest 1994; 93: 1179-1185.
65. Weese-Mayer DE, Silvestri JM, Lin D, et al. Effect of cocaine in early gestation on striatal dopamine and neurotrophic activity. Pediatr Res 1993; 34: 389-392.
66. Seidler FJ, Slotkin TA. Prenatal cocaine and cell development in rat brain regions: effects on ornithine decarboxylase and macromolecules. Brain Res Bull 1993; 30: 91-99.
67. Gressens P, Kosofsky BE, Evard P. Cocaine-induced disturbances of corticogenesis in the developing murine brain. Neurosci Lett 1992; 140: 113-116.
68. Kaufmann WE. Developmental cortical anomalies after prenatal exposure to cocaine. Soc Neurosci 1990; 16: 305.
69. Karler R, Calder LD. Excitatory amino acids and the actions of cocaine. Brain Res 1992; 582: 143-146.
70. Lin Y, Leskawa KC. Cytotoxicity of the cocaine metabolite benzoylecgonine. Brain Res 1994; 643: 108-114.
71. Hughes P, Dragunow M. Induction of immediate early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol Rev 1995; 47: 133-178.
72. Fosnaugh JS, Bhat RV, Yamagata K, et al. Activation of arc, a putative 'effector' immediate early gene by cocaine in rat brain. J Neurochem 1995; 64: 2377-2380.
73. Kosofsky BE, Genove LM, Hyman SE. Substance P phenotype defines specificity of c-fos induction by cocaine in developing rat striaturn. J Comp Neurol 1995; 351: 41-50.
74. Chiriboga CA, Bateman DA, Brust JCM, Hauser WA. Neurologic findings in neonates with intrauterine cocaine exposure. Pediatr Neurol 1993; 9: 115-119.
75. Smit BJ, Boer K, Van Huis AM, et al. Cocaine use in pregnancy in Amsterdam. Acta Paediatr 1994; 404: 32-35.
76. Betancourt Y, Jiménez JC. Teratogenicidad y secuelas neurológicas de la exposición intrauterina a la cocaina. Rev Neurol 1996; 24: 1457-1458.
77. Bingol N, Fuchs M, Diaz V, et al. Teratogenicity of cocaine use. J Pediatr 1987; 110: 93-96.
78. Fries MH, Kuller JA, Norton ME. Facial features of infants exposed prenatally to cocaine. Teratology 1993; 48: 413-420.
79. Hannig VA, Philips JA. Maternal cocaine abuse and fetal abnormality: evidence for teratogenic effects of cocaine. South Med J 1991; 84: 498-499.
80. Domínguez R, Vila-Coro A, Slopis JM, et al. Brain and ocular abnormalities in infants with in utero exposure to cocaine and other street drugs. Am J Dis Child 1991; 145: 688-695.
81. Heier LA, Carpanzano CR, Mast J, et al. Maternal cocaine abuse: the spectrum of radiologic abnormalities in the neonatal CNS. AJNR 1991; 12: 951-956.
82. Stafford JR, Rosen TS, Zaider M, Merriam JC. Prenatal cocaine exposure and the development of the human eye. Ophtalmology 1994; 101: 301-308.
83. Beltran RS, Coker SB. Transient dystonia of infancy, a result of intrauterine cocaine exposure? Pediatr Neurol 1995; 12: 354-356.
84. Napiokowski B, Lester BM, Freier MC, et al. Effects of in utero substance exposure on infant behavior. Pediatrics 1996; 98: 71-75.
85. Tronick EZ, Frank DA, Cabral H, et al. Late dose-response effects of prenatal cocaine exposure on newborn neurobehavioral performance. Pediatrics 1996; 98: 76-83.
86. Delaney-Black V, Covington C, Ostrea E, et al. Prenatal cocaine and neonatal outcome: evaluation of dose-response relationship. Pediatrics 1996; 98: 735-740.
87. Dixon SD, Bejar R. Echoencephalographic findings in neonates with maternal cocaine and metamphetamine use: incidence and clinical correlates. J Pediatr 1989; 115: 770-778.
88. Kramer DL, Locke GE, Ogungeni A, Nelson L. Neonatal cocaine-related seizures. J Child Neurol 1990; 5: 60-64.
89. Silvestri JM, Long JM, Weese-Mayer DE, Barkov GA. Effects of prenatal cocaine on respiration, heart rate and sudden infant death syndrome. Pediatr Pulmonol 1991; 11: 328-334.
90. Kandall SR, Gaines J, Habel L, et al. Relationship of maternal substance abuse to subsequent infant death in offspring. J Pediatr 1993; 123: 120-126.
91. Suguihara C, Hehre D, Huang J, et al. Decreased ventilatory response to hypoxia in sedated newborn piglets prenatally exposed to cocaine. J Pediatr 1996; 128: 389-395.
92. Howard J, Beckwith L, Espinosa M, Tyler R. Development of infants born to cocaine-abusing women: biologic/maternal influences. Neuro-toxicol Teratol 1995; 17: 403-411.
93. Jacobson SW, Jacobson JL, Sokol RJ, et al. New evidence for neurobehavioral effects of in utero cocaine exposure. J Pediatr 1996; 129: 581-590.
94. Fetters L, Tronick EZ. Neuromotor development of cocaine-exposed and control infants from birth through 15 months: poor and poorer performance. Pediatrics 1996; 98: 938-943.
95. Azuma SD, Chasnoff IJ. Outcome of children prenatally exposed to cocaine and other drugs: a path analysis of three year data. Pediatrics 1993; 92: 396-402.
96. Bender SL, Word CO, DiClemente RJ, et al. The developmental implications of prenatal and/or postnatal crack cocaine exposure in preschool children: a preliminary report. J Dev Behav Pediatr 1995; 16: 418-424.
97. Davis E, Fenoy I, Laraque D, et al. Autism and developmental abnormalities in children with perinatal cocaine exposure. J Nation Med Assoc 1992; 84: 315-319.
98. Doberczak TM, Shanzer S, Senie RT, Kandall SR. Neonatal neurologic and electroencephalographic effects of intrauterine exposure. J Pediatr 1988; 113: 354-358.
99. Legido A, Clancy RR, Spitzer A, Finnegan LP. Electroencephalographic and behavioral-state studies in infants of cocaine-addicted mothers. AJDC 1992; 146: 748-752.
100. Shih L, Cone-Wesson B, Reddix C. Effects of maternal cocaine abuse on the neonatal auditory system. Int J Ped Otorhinolaryngol 1988; 15: 245-251.
101. Salamy A, Eldredge L, Anderson J, Bull D. Brain-stem transmission time in infants exposed to cocaine in utero. J Pediatr 1990; 117: 627-629.
102. Tyrala EE, Legido A, Wavrek D, Martin WH. Peripheral auditory function in infants exposed to cocaine in utero. Pediatr Res 1991; 29: 237A.
103. Tyrala EE, Legido A, Wavrek D, et al. Exposure to cocaine in utero does not affect brain stem auditory evoked resposes (BAERs) in very low birthweight infants. Pediatr Res 1993; 33: 240A.
104. 99mTc-HMPAO SPECT scans in symptomatic neonates exposed to cocaine. J Child Neurol 1994; 9: 278-280.
105. Chugani HT. Positron Emission Tomography (PET) in substance-abuse exposed infants: a preliminary report. En Konkol RJ, Olsen GD, eds. Prenatal cocaine exposure. Boca Raton: CRC Press, 1996; 183-186.
106. Ellickson PL, Bell RM, McGuigan K. Preventing adolescent drug use: long-term results of a junior high program. Am J Public Health 1993; 83: 856-861.
107. Casado-Flores J, Baño-Rodrigo A, Romero E. Social and medical pro-blems in children of heroin-addicted parents. AJDC 1990; 144: 977-979.
108. DiChiara G, North RA. Neurobiology of opiate abuse. Trends Pharmacol Sci 1992; 13: 185-193.
109. Koob GF. Neural substrates of opiate withdrawal. TINS 1992; 15: 186-190.
110. Nestler EJ. Molecular mechanisms of drug addiction. J Neurosci 1992; 12: 2439-2450.
111. Soepatmi S. Developmental outcomes of children of mothers dependent on heroin or heroin/methadone during pregnancy. Acta Paediatr 1994; 404: 36-39.
112. Barr GA, Jones K. Opiate withdrawal in the infant. Neurotoxicol Teratol 1994; 16: 219-225.
113. Navarro M, Rubio P, Rodriguez de Fonseca F. Behavioural consequences of maternal exposure to natural cannabinoids in rats. Physcophar-macology 1995; 122: 1-14.
114. Zuckerman B, Frank DA, Hingson R, et al. Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med 1989; 320: 762-768.
115. Hingson R, Alpert TT, Day N, et al. Effects of maternal drinking and marijuana use on fetal growth and development. Pediatrics 1982; 70: 539-546.
116. Cornelius MD, Taylor PM, Geva D, Day NL. Prenatal tobacco and marijuana use among adolescents: effects on offspring gestational age, growth, and morphology. Pediatrics 1995; 95: 738-743.
117. Fried PA. Postnatal consequences of maternal marijuana use during pregnancy: consequences for the offspring. Semin Perinatol 1991; 15: 280-287.
118. Richardson GA, Day NL, Goldschmidt L. Prenatal alcohol, marijuana, and tobacco use: infant mental and motor development. Neurotoxicol Teratol 1995; 17: 479-487.
119. Griffith DR, Azuma S, Chasnoff IJ. Three-year outcome of children exposed prenatally to drugs. J Am Acad Child Adolesc Psychiatry 1994; 33: 20-27.
120. Dahl RE, Scher MS, Williamson DE, et al. A longitudinal study of prenatal marijuana use. Effects on sleep and arousal at age 3 years. Arch Pediatr Adolesc Med 1995; 149: 145-150.